Odette Hauke

Odette Hauke, MS, serves as the Director of Regulatory Affairs at Vera Therapeutics, Inc. since June 2025, and as a Global Regulatory Affairs Consultant since August 2022, focusing on innovative regulatory strategies in psychedelics, rare diseases, and neuropsychiatry, while collaborating with prominent industry leaders like Johnson & Johnson and Regeneron Pharmaceuticals. Previously, Odette held positions including Associate Director of Regulatory Affairs at atai Life Sciences, Manager of Regulatory Affairs at Travere Therapeutics, and Senior Specialist in Regulatory Affairs at Regeneron. Odette's regulatory experience also includes significant roles at Memorial Sloan Kettering Cancer Center and other institutions. Odette holds a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science in Epidemiology from CUNY.